GB2063864B - X-ray amorphous physiologically acceptable acid addition salts of ergot alkaloids and dihydroergot alkaloids and their use in therapy - Google Patents

X-ray amorphous physiologically acceptable acid addition salts of ergot alkaloids and dihydroergot alkaloids and their use in therapy

Info

Publication number
GB2063864B
GB2063864B GB8037133A GB8037133A GB2063864B GB 2063864 B GB2063864 B GB 2063864B GB 8037133 A GB8037133 A GB 8037133A GB 8037133 A GB8037133 A GB 8037133A GB 2063864 B GB2063864 B GB 2063864B
Authority
GB
United Kingdom
Prior art keywords
alkaloids
therapy
acid addition
addition salts
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8037133A
Other languages
English (en)
Other versions
GB2063864A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals and Chemical Co dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals and Chemical Co dd filed Critical Lek Pharmaceuticals and Chemical Co dd
Publication of GB2063864A publication Critical patent/GB2063864A/en
Application granted granted Critical
Publication of GB2063864B publication Critical patent/GB2063864B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GB8037133A 1979-11-22 1980-11-19 X-ray amorphous physiologically acceptable acid addition salts of ergot alkaloids and dihydroergot alkaloids and their use in therapy Expired GB2063864B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU2867/79A YU41681B (en) 1979-11-22 1979-11-22 Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids

Publications (2)

Publication Number Publication Date
GB2063864A GB2063864A (en) 1981-06-10
GB2063864B true GB2063864B (en) 1983-07-20

Family

ID=25558910

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8037133A Expired GB2063864B (en) 1979-11-22 1980-11-19 X-ray amorphous physiologically acceptable acid addition salts of ergot alkaloids and dihydroergot alkaloids and their use in therapy

Country Status (10)

Country Link
JP (1) JPS56164195A (fr)
BE (1) BE886262A (fr)
DE (1) DE3043832A1 (fr)
ES (1) ES496969A0 (fr)
FR (1) FR2470133A1 (fr)
GB (1) GB2063864B (fr)
LU (1) LU82945A1 (fr)
NL (1) NL8006341A (fr)
PT (1) PT72078B (fr)
YU (1) YU41681B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87190A1 (fr) * 1988-04-06 1989-11-14 Wurth Paul Sa Machine de percage de trous de coulee d'un four a cuve

Also Published As

Publication number Publication date
NL8006341A (nl) 1981-06-16
YU286779A (en) 1983-06-30
GB2063864A (en) 1981-06-10
PT72078B (en) 1981-09-29
FR2470133A1 (fr) 1981-05-29
ES8205796A1 (es) 1982-08-01
FR2470133B3 (fr) 1982-09-03
ES496969A0 (es) 1982-08-01
LU82945A1 (de) 1981-03-26
DE3043832A1 (de) 1981-09-17
JPS56164195A (en) 1981-12-17
YU41681B (en) 1987-12-31
PT72078A (en) 1980-12-01
BE886262A (fr) 1981-03-16

Similar Documents

Publication Publication Date Title
NZ194703A (en) Tertiary-butylamine salt of clavulanic acid and use in preparation of clavulanic acid
NZ224361A (en) Preparation of (6s)-folinic acid and its salts
JPS5655386A (en) *** catechine salts* manufacture of their salts and therapeutic drug containing them
IL55043A0 (en) Quinolonecarboxylic acid derivatives and their use as bactericides
DE3263917D1 (en) Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof
ZA803539B (en) Alkoxybenzylrimidines method for their preparation formulation thereof and their use in medicine
GB2060633B (en) Isocyanuric acid derivatives preparation and pharmaceutical use thereof
GB2022411B (en) Para-aminobencoic acid derivatives for use in therapy
GB2063864B (en) X-ray amorphous physiologically acceptable acid addition salts of ergot alkaloids and dihydroergot alkaloids and their use in therapy
NZ195099A (en) 2-amino-4-substitutedthiazol-5-ylcarboxylic acid derivatives and use thereof in the preparation of herbicidal safening agents
JPS5623951A (en) Bed for patient available in urine and excrement exhausion
JPS5498774A (en) Arylethers and acid addition salts of nnalkylpiperidine
EP0000633A3 (en) 2,5 -disubstituted-3-substituted methyl-penta-2,4-dienoic acid and derivatives, process for their preparation and their use in the preparation of alpha-substituted-thien-3-yl acetic acid and derivatives
IL61447A0 (en) Stable solutions of hydrogenated ergot alkaloids and their preparation
EP0018550A3 (en) Use of physiologically acceptable methyl donors in preparing compositions for muscular disease treatment and compositions containing these methyl donors
GB2025960B (en) Pharmaceutically and veterinarily acceptable acid addition salts of dextrorotatory ergot alkaloids
DE2967615D1 (en) Tetrahydropyridinyl indole derivatives and their salts for use in a method for therapeutic treatment of the human or animal body and pharmaceutical compositions containing them
HU178306B (en) Process for preparing pharmaceutically active /omega-amino-alkoxy/-dibenzyl derivatives and acid addition salts thereof
GB2025394B (en) Benzoylphenoxyalkanoic acid derivatives their use and preparation
EP0321428A3 (en) Use of glycerol ethers in dermatological diseases
GB2019720B (en) Adenosyl-l-homocysteine and salts thereof for use in therapy
ZA781685B (en) Furoyl-and thenoyl-aryloxyalkyl carboxylic acid derivatives,their preparation and their use in therapy
DE2860653D1 (en) Derivatives of ergoline, method for their preparation, pharmaceutical compositions containing them and their application for use in therapy
DE3062168D1 (en) Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions
EG13550A (en) Method of preparation of pyrimidine derivatives and used for therapy of atheromas

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee